Intech Investment Management LLC Xeris Biopharma Holdings, Inc. Transaction History
Intech Investment Management LLC
- $10.8 Billion
- Q3 2025
A detailed history of Intech Investment Management LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 55,336 shares of XERS stock, worth $401,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,336
Previous 94,437
41.4%
Holding current value
$401,186
Previous $441,000
1.59%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
234Shares Held
95.5MCall Options Held
269KPut Options Held
61K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...